Table 4.
Univariate and multivariate analyses for death of all patients with LC (n = 145).
| Variables | Univariable analysis | Multivariable analysis | ||
|---|---|---|---|---|
| HR (95% CI) | P -value | HR (95% CI) | P- value | |
| Age | ||||
| (>61 vs. ≤61years) | – | 0.811 | – | – |
| Gender | ||||
| (male vs. female) | 3.865 (2.321–6.435) | 0.000 | 2.187 (1.284–3.726) | 0.004 |
| ECOG | ||||
| (2,3 vs. 0,1) | 5.107 (2.832–9.210) | 0.000 | – | 0.136 |
| TNM clinical stage | ||||
| (IIIb,IV vs. I–IIIa) | 8.934 (4.053–19.694) | 0.000 | 8.754 (3.844–19.934) | 0.000 |
| Pathology | ||||
| (SCLC vs. NSCLC) | 2.024 (1.052–3.895) | 0.045 | – | 0.849 |
| Smoking history | ||||
| (yes vs. no) | 3.443 (2.054–5.770) | 0.000 | – | 0.385 |
| CTD | ||||
| With CTD vs. without CTD | 2.685 (1.554–4.638) | 0.000 | 4.452 (2.489–7.963) | 0.000 |
| Pulmonary embolism | ||||
| (yes vs. no) | 2.895 (1.412–5.936) | 0.004 | – | 0.085 |
SCLC, small cell lung cancer; NSCLC, non–small cell lung cancer; -, not applicable.